Back to Guides
🧬 Biotech Beginner ⏱ 35 min

How to Use CRISPR Gene Editing: From Casgevy to Base and Prime Editing

CRISPR-Cas9 has revolutionized genetic engineering, making gene editing accessible, affordable, and precise. This beginner-friendly guide explains how CRISPR works, its applications, and the ethical landscape.

How to Use CRISPR Gene Editing: From Casgevy to Base and Prime Editing

Introduction

CRISPR-Cas9 has revolutionized genetic engineering, making gene editing accessible, affordable, and precise. This beginner-friendly guide explains how CRISPR works, its applications, and the ethical landscape.

Prerequisites

  • Basic understanding of DNA structure (double helix, base pairs)
  • Familiarity with genes and proteins
  • No advanced biology required

Key Concepts

CRISPR
Clustered Regularly Interspaced Short Palindromic Repeats — a bacterial immune system adapted for gene editing.
Cas9
An enzyme (CRISPR-associated protein 9) that cuts DNA at a specific location guided by an RNA sequence.
Guide RNA (gRNA)
A short RNA sequence that directs Cas9 to the target DNA location.
PAM Sequence
A short DNA sequence (NGG for Cas9) that must be adjacent to the target site for Cas9 to cut.

Step-by-Step Guide

  1. 1

    Understand the Natural CRISPR System

    CRISPR was originally discovered as part of the bacterial immune system. When a bacterium is infected by a virus, it saves a snippet of the viral DNA in its CRISPR locus. If the same virus attacks again, the bacterium uses that saved DNA as a guide RNA to direct Cas9 to cut and destroy the viral DNA.

    💡
    Tip: The Nobel Prize in Chemistry 2020 was awarded to Jennifer Doudna and Emmanuelle Charpentier for discovering CRISPR-Cas9 as a gene editing tool.
  2. 2

    Learn How Guide RNA Targets DNA

    The guide RNA (gRNA) is a 20-nucleotide sequence that matches the target DNA. It binds to Cas9, forming a complex that scans DNA for a matching sequence. When it finds a match adjacent to a PAM sequence, Cas9 cuts the DNA.

    The Cas9 protein complex with guide RNA — the molecular machine that makes gene editing possible.
    The Cas9 protein complex with guide RNA — the molecular machine that makes gene editing possible.
  3. 3

    Understand DNA Repair Mechanisms

    After Cas9 cuts the DNA, the cell repairs the break using one of two pathways: Non-Homologous End Joining (NHEJ) — error-prone, often introduces small insertions or deletions that knock out the gene. Homology-Directed Repair (HDR) — uses a template to make precise edits, but is less efficient.

    ⚠️
    Warning: HDR efficiency is typically 10-30% in dividing cells and much lower in non-dividing cells. This is a major limitation for therapeutic applications.
  4. 4

    Design Your Guide RNA

    To edit a specific gene, you need to design a gRNA that targets the right location. Use online tools like Benchling or CRISPOR to find optimal target sites. Consider: PAM presence, off-target effects, and proximity to the desired edit site.

    text
    Target: 5'-GAGTCCGAGCAGAAGAAGAANGG-3'
    Guide:  5'-GAGTCCGAGCAGAAGAAGAA-3'
    PAM:                       NGG
    Off-target score: 0.12 (good)
    Efficiency score: 0.78 (high)
  5. 5

    Choose Your Delivery Method

    For cells in a lab: electroporation or lipofection to deliver Cas9 protein + gRNA directly. For therapeutic applications: AAV viral vectors for in vivo delivery, or lipid nanoparticles for ex vivo editing of harvested cells.

    💡
    Tip: Direct delivery of Cas9 ribonucleoprotein (RNP) is preferred for research — it is active immediately and degrades within 24-48 hours, reducing off-target effects.
  6. 6

    Verify Your Edit

    After editing, verify the results using PCR and sequencing. Sanger sequencing with TIDE analysis can quantify editing efficiency. For clonal populations, whole-genome sequencing can check for off-target effects.

    ⚠️
    Warning: Always check for off-target edits, especially for therapeutic applications. Even with high-specificity gRNAs, off-target effects can occur at similar sequences.
  7. 7

    Explore Therapeutic Applications

    CRISPR therapeutics are now reality. Casgevy (exa-cel) was the first FDA-approved CRISPR therapy, treating sickle cell disease by editing hematopoietic stem cells ex vivo. In vivo CRISPR therapies for liver, eye, and muscle diseases are in clinical trials.

    Ex vivo CRISPR editing of hematopoietic stem cells — the approach used in the first approved CRISPR therapy.
    Ex vivo CRISPR editing of hematopoietic stem cells — the approach used in the first approved CRISPR therapy.
  8. 8

    Understand the Ethical Landscape

    CRISPR raises profound ethical questions. Somatic editing (body cells, affects only the patient) is widely accepted. Germline editing (embryos, affects all descendants) is banned in most countries. The 2018 case of CRISPR-edited babies in China sparked global outrage and calls for regulation.

    💡
    Tip: Stay informed about evolving regulations. The WHO, FDA, and EMA all have working groups on CRISPR ethics and regulation.
  9. 9

    Learn About CRISPR Variants

    Beyond Cas9, the CRISPR toolbox includes: Cas12a (different PAM, creates staggered cuts), Cas13 (targets RNA instead of DNA), Base editors (change individual bases without cutting), Prime editors (search-and-replace editing without double-strand breaks).

  10. 10

    Stay Current with the Field

    CRISPR is evolving rapidly. Key areas to watch: in vivo delivery improvements, prime editing efficiency, epigenome editing (changing gene expression without changing DNA sequence), and CRISPR diagnostics (detecting viral DNA with CRISPR).

Summary

CRISPR-Cas9 is a bacterial immune system repurposed as the most powerful gene editing tool ever developed. It uses a guide RNA to direct the Cas9 enzyme to a specific DNA location, where it makes a cut that the cell repairs — either disrupting a gene (NHEJ) or making a precise edit (HDR). CRISPR therapeutics are now FDA-approved, and the field continues to evolve with new variants like base editors and prime editors.

Frequently Asked Questions

The first CRISPR therapy (Casgevy) has 3-year follow-up data showing 94% efficacy with no serious adverse events. However, long-term safety monitoring is ongoing, and off-target effects remain a concern for new applications.

Research-grade CRISPR reagents cost $50-500. The first CRISPR therapy (Casgevy) costs $2.2M per patient — but this reflects the full treatment process, not just the CRISPR reagents.

CRISPR is being used in CAR-T cell therapies to engineer immune cells that target cancer. Several CRISPR-based cancer therapies are in clinical trials, but none are yet FDA-approved.

CRISPR is a gene editing tool — it changes existing DNA. Traditional gene therapy adds a new gene without editing existing ones. CRISPR is more precise but also more complex.

Test Your Knowledge

1. What is the role of the PAM sequence in CRISPR?

The PAM (Protospacer Adjacent Motif) is a short DNA sequence that Cas9 must recognize adjacent to the target site. Without it, Cas9 will not cut, even if the guide RNA matches.

2. Which DNA repair pathway is used for precise gene editing?

HDR uses a DNA template to make precise, planned edits. NHEJ is error-prone and typically used for gene knockout.

3. What is the main advantage of base editors over standard CRISPR?

Base editors fuse a deaminase enzyme to Cas9, allowing them to change one base to another without creating a double-strand break, reducing the risk of unwanted insertions or deletions.

Score: 0 / 3